Press releases 2011

10 | 11 | 11

GATC Biotech expands its sequencing laboratories in Constance and Cologne

30 new jobs are planned in 2012

Europe’s leading sequencing service provider GATC Biotech continues to grow in 2012. The company will expand the laboratories at its headquarters in Constance and plans to establish a new site in Cologne, Germany.

The premises in Constance will become the new European Genome...

10 | 10 | 11

Internationalization is firmly anchored in the company DNA

The establishment of a subsidiary in London in 2004 heralded the presence on the international market of Konstanz-based GATC, which now has subsidiaries in England, France and Sweden comprising a total of

11 | 08 | 11

Sequenom announces European licensing agreement with GATC daughter LifeCodexx

San Diego, Calif./Konstanz, Germany - Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of...

21 | 07 | 11

GATC Biotech and the ETH Zurich to establish Method for Quality Assurance in Food Production

Method to be based on Multiplatform Sequencing including the new PacBio RS system

GATC Biotech, in collaboration with the Institute of Food, Nutrition and Health at the Swiss Federal Institute of Technology Zurich (ETH Zurich), is developing a cost efficient method for taxonomic characterization of microbial...

28 | 06 | 11

Successful start of the clinical validation study of the non-invasive, prenatal diagnostic test for the determination of trisomy 21

Method based on Illumina HiSeq 2000 validated

In conjunction with several Central European prenatal centers, scientists at GATC Biotech AG and LifeCodexx AG have begun the clinical validation study of a non-invasive diagnostic test based on next...

12 | 05 | 11

GATC Biotech and LifeCodexx develop a diagnostic test for early detection of preeclampsia

Project is funded with 500,000 Euros from the BMBF

Preeclampsia  is a hypertensive disorder of the mother during pregnancy. It is among the leading causes of death of mother and unborn child and occurs in approximately two to five percent of all pregnancies in Germany. Early detection is critical and improves...

14 | 04 | 11

Successful pilot study for non-invasive prenatal diagnostic test to determine trisomy 21

Launch planned for end of 2011

At the moment, the only reliable way of diagnosing chromosomal irregularities during pregnancy is to use invasive prenatal methods. This causes miscarriage in about one per cent of these risky surgical procedures.
 
Scientists from the Center for Prenatal Diagnosis and...

25 | 02 | 11

GATC Biotech Ltd. once again becomes a preferred supplier to the Research Councils of the UK

Following the previously won tender of 2006, GATC Biotech Ltd. (London) has again been selected as a preferred supplier of DNA sequencing by the Research Councils UK Shared Services Centre Ltd (RCUK SSC Ltd.) until the end of 2012....

27 | 01 | 11

Mayor Horst Frank: GATC is a Constance flagship company

The GATC Biotech management and employees welcomed local political and industrial leaders, the architect, and construction companies to celebrate the inauguration of the newly constructed GATC facilities in Constance.

For Mayor Horst Frank GATC Biotech is a model company for the area. He looks forward to many imitators,...